Literature DB >> 36073704

The future of CBT and evidence-based psychotherapies is promising.

Michelle G Craske1.   

Abstract

Entities:  

Year:  2022        PMID： 36073704      PMCID： PMC9453923          DOI： 10.1002/wps.21002

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   79.683


× No keyword cloud information.
  7 in total

1.  Correction to 'State-of-the-art and future directions for extinction as a translational model for fear and anxiety'.

Authors:  Michelle G Craske; Dirk Hermans; Bram Vervliet
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-10-08       Impact factor: 6.237

Review 2.  Without Wasting a Word: Extreme Improvements in Efficiency and Accuracy Using Computerized Adaptive Testing for Mental Health Disorders (CAT-MH).

Authors:  Robert D Gibbons; Frank V deGruy
Journal:  Curr Psychiatry Rep       Date:  2019-07-01       Impact factor: 5.285

3.  Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia.

Authors:  Michelle G Craske; Alicia E Meuret; Thomas Ritz; Michael Treanor; Halina Dour; David Rosenfield
Journal:  J Consult Clin Psychol       Date:  2019-05

Review 4.  The impact of digital technology on psychological treatments and their dissemination.

Authors:  Christopher G Fairburn; Vikram Patel
Journal:  Behav Res Ther       Date:  2017-01

5.  Development and initial implementation of the Dynamic Assessment Treatment Algorithm (DATA).

Authors:  Katya C Fernandez; Aaron J Fisher; Cyrus Chi
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240

6.  Scale up task-sharing of psychological therapies.

Authors:  Vikram Patel
Journal:  Lancet       Date:  2021-12-17       Impact factor: 79.321

7.  Stratified Care vs Stepped Care for Depression: A Cluster Randomized Clinical Trial.

Authors:  Jaime Delgadillo; Shehzad Ali; Kieran Fleck; Charlotte Agnew; Amy Southgate; Laura Parkhouse; Zachary D Cohen; Robert J DeRubeis; Michael Barkham
Journal:  JAMA Psychiatry       Date:  2022-02-01       Impact factor: 21.596
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.